Investment
Features
FeesSafety
Academy
More
Pluang+

Compare State Street SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) vs Procter & Gamble Co (PG) Price & Performance

State Street SPDR Bloomberg 1-3 Month T-Bill ETFTrade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

State Street SPDR Bloomberg 1-3 Month T-Bill ETF vs Procter & Gamble Co — how do they compare? State Street SPDR Bloomberg 1-3 Month T-Bill ETF trades at $91.49, while Procter & Gamble Co trades at $145.1 (market cap $340.39B). The key difference: Procter & Gamble Co pays a 2.97% dividend while State Street SPDR Bloomberg 1-3 Month T-Bill ETF pays none, and State Street SPDR Bloomberg 1-3 Month T-Bill ETF is trading nearer its 52-week high, Procter & Gamble Co nearer its low. Which is the better fit depends on your goals.

BILPG
Sector
Fixed IncomeConsumer Staples
52-Week High
$91.77$167.18
52-Week Low
$91.27$138.10
Market Cap
$340.39B
Volume
6,423,436
Enterprise Value
$366.23B
Dividend Yield
2.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

State Street SPDR Bloomberg 1-3 Month T-Bill ETF

BIL trades at $91.48 with minimal daily movement (+0.03%), showing stability amid market volatility. The ETF maintains consistent dividend distributions of $0.27 per share quarterly, with recent institutional buying activity indicating professional confidence. Technical indicators show bearish momentum with moving averages signaling caution, though oscillators suggest potential stabilization near current levels.

As a short-term Treasury ETF, BIL offers capital preservation and steady income through Treasury bill exposure. Key risks include interest rate sensitivity and inflation pressures affecting Treasury yields. The fund's defensive positioning appeals to risk-averse investors seeking liquidity and minimal credit risk in uncertain markets.

Procter & Gamble Co

Procter & Gamble (PG) trades at $144.77, down 0.69% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The company maintains strong fundamentals with $84.28B revenue, 18.44% net margin, and consistent dividend payments, though valuation multiples remain elevated versus peers. Recent news highlights institutional positioning shifts and the company's new WNBA partnership.

PG offers stable cash flows and dividend growth potential but faces premium valuation concerns and modest revenue growth outlook. Near-term catalysts include Q3 2026 earnings, while risks include competitive pressures and economic sensitivity. Analyst consensus remains positive with a $161.20 price target suggesting 11% upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About State Street SPDR Bloomberg 1-3 Month T-Bill ETF

BIL tracks the performance of short-term U.S. Treasury bills with maturities between 1 and 3 months. It is designed for investors seeking a highly liquid, low-risk vehicle for cash management and capital preservation.

Read more on BIL

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG